Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Areas with lower population density have not seen the same slowdown as urban areas.
Readily available clinical parameters can identify those at greatest risk for hepatocellular carcinoma.
October is Liver Cancer Awareness Month.
Many people with fatty liver disease have obesity, diabetes and other metabolic conditions.
NAFLD is the leading indicator of mortality among Medicare beneficiaries with hepatocellular carcinoma.
Transplants due to hepatitis C have declined dramatically thanks to effective treatment.
Those with fatty liver disease and cirrhosis should undergo regular screening.
Smoking cessation, moderate drinking, a healthy diet, exercise and weight loss could dramatically reduce the growing burden of liver cancer.
People with liver cirrhosis often have substantial financial burden that interferes with their care.
A study found that people who had the largest increase in whole grain lowered their liver cancer risk by nearly 40 percent.
A new study examines the clinical and economic impact of new direct-acting antivirals.
Hepatitis B patients who used aspirin therapy had a 37 percent lower rate of hepatocellular carcinoma.
With the exception of colon cancer, most cancers associated with overweight or obesity rose over the past decade.
Opdivo will be used to treat hepatocellular carcinoma, which can be caused by hepatitis B or C.
Men and people over age 50 still may still develop liver cancer after clearing the virus from the blood.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.